A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy of Alginate oligosaccharide (OligoG) dry
powder for inhalation in cystic fibrosis (CF) patients with a Burkholderia spp. infection.